Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Asahi Kasei Finishes Second Plant for Ceolus Microcrystalline Cellulose | Contract Pharma

What are you searching for?

Sign in

Asahi Kasei Finishes Second Plant for Ceolus Microcrystalline Cellulose

The plant is intended to raise supply capacity and enhance the supply stability through production at multiple sites.

By: Anthony Vecchione

Asahi Kasei has completed the construction of its second plant for Ceolus microcrystalline cellulose (MCC), a tablet binder for pharmaceuticals.

The new facility in Okayama, Japan, underscores the company’s commitment to meet the substantially growing demand for its MCC product.

According to the company, demand for Ceolus is growing, most notably for the proprietary high-performance grades Ceolus.

“The increased capacity at this new plant will enable us to provide a more stable supply of Ceolus for distribution centers around the world to get products to customers in greater quantities,” said Eiichi Hori, senior general manager of functional additives division. “The second plant will make Ceolus more accessible to patients around the world. We are excited to see the innovative, new formulations that pharmaceutical and supplement manufacturers will develop utilizing our MCC.”

The second plant is intended to raise supply capacity and enhance the supply stability through production at multiple sites. The new plant is currently undergoing trial operation, with commercial production of each grade scheduled to begin in succession from April 2023.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics